Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Vis graf over relationer


Responsible for the production of cellular products for patients treated with immunotherapy.

Primære forskningsområder

Research focus is in the area of molecular and cellular tumor immunology which includes both basic research and development of novel molecular immunotherapeutic strategies for treatment of cancer. 

Aktuel forskning

Develop isolation and expansion methods for tumor-infiltrating lymphocyte (TIL) and to produce large-scale GMP-grade TIL products for adoptive cell therapy (ACT) clinical trials for melanoma and other solid tumors.
Development and exploitation of novel costimulatory chimeric antigen receptors (CARs) to be used ACT studies.


ID: 32285840